--- title: "輝瑞兩款三抗在中國啓動 2 期臨牀 治療特應性皮炎" description: "7 月 23 日,中國藥物臨牀試驗登記與信息公示平台顯示,輝瑞在國內登記了一項Ⅱ期臨牀試驗,以評估 PF-07275315 和 PF-07264660 在中度至重度特應性皮炎成人受試者中的療效和安全性。其中,PF-07275315 是一款靶向 IL-4×IL-13×TSLP 的三特異性抗體,PF-07264660 是一款靶向 IL-4×IL-13×IL-33 的三特異性抗體。特應性皮炎 (AD) " type: "news" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/209684360.md" published_at: "2024-07-24T08:38:03.000Z" --- # 輝瑞兩款三抗在中國啓動 2 期臨牀 治療特應性皮炎 > 7 月 23 日,中國藥物臨牀試驗登記與信息公示平台顯示,輝瑞在國內登記了一項Ⅱ期臨牀試驗,以評估 PF-07275315 和 PF-07264660 在中度至重度特應性皮炎成人受試者中的療效和安全性。其中,PF-07275315 是一款靶向 IL-4×IL-13×TSLP 的三特異性抗體,PF-07264660 是一款靶向 IL-4×IL-13×IL-33 的三特異性抗體。特應性皮炎 (AD) 是一種常見的慢性、複發性、炎症性皮膚病。IL-4 和 IL-13 是 AD 發病的重要細胞因子,在 AD 的發生發展中起着關鍵作用。輝瑞擬開發這兩款三抗藥物用於治療特應性皮炎適應症。在海外,這兩款在研新藥此前已進入 2 期臨牀試驗階段。 智通財經 APP 獲悉,7 月 23 日,中國藥物臨牀試驗登記與信息公示平台顯示,輝瑞 (PFE.US) 在國內登記了一項Ⅱ期臨牀試驗,以評估 PF-07275315 和 PF-07264660 在中度至重度特應性皮炎成人受試者中的療效和安全性。其中,PF-07275315 是一款靶向 IL-4×IL-13×TSLP 的三特異性抗體,PF-07264660 是一款靶向 IL-4×IL-13×IL-33 的三特異性抗體。 ![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20240724/1721809966998891.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg "1721809966998891.png") 特應性皮炎 (AD) 是一種常見的慢性、複發性、炎症性皮膚病。IL-4 和 IL-13 是 AD 發病的重要細胞因子,在 AD 的發生發展中起着關鍵作用。 輝瑞擬開發這兩款三抗藥物用於治療特應性皮炎適應症。在海外,這兩款在研新藥此前已進入 2 期臨牀試驗階段。 ### Related Stocks - [PFE.US - 輝瑞](https://longbridge.com/zh-HK/quote/PFE.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | This 6.75%-Yielding Dividend Stock Can Gain 33% | Pfizer (NYSE:PFE) shares surged nearly 7% following a pricing deal with the Trump administration, marking a significant | [Link](https://longbridge.com/zh-HK/news/259690001.md) | | TrumpRx Brings Pfizer Into the Green—Is It a Buy? | Pfizer has entered a significant agreement with the U.S. government to lower drug costs, which has positively impacted i | [Link](https://longbridge.com/zh-HK/news/260151683.md) | | OXY-Clean: Buffett's Favourite Oil Rig Scrubs $6 Billion In Debt Off The Books | Occidental Petroleum Corp (NYSE:OXY) has significantly reduced its debt by $5.8 billion after selling its OxyChem divisi | [Link](https://longbridge.com/zh-HK/news/276372720.md) | | IronBridge Private Wealth LLC Has $905,000 Holdings in Apple Inc. $AAPL | IronBridge Private Wealth LLC reduced its stake in Apple Inc. (NASDAQ:AAPL) by 77.3% in Q3, holding 3,555 shares valued | [Link](https://longbridge.com/zh-HK/news/276436345.md) | | Financial Advocates Investment Management Lowers Stock Position in Meta Platforms, Inc. $META | Financial Advocates Investment Management reduced its stake in Meta Platforms, Inc. by 66.7% in Q3, now holding 2,343 sh | [Link](https://longbridge.com/zh-HK/news/276432394.md) | --- > **免責聲明**:本文內容僅供參考,不構成任何投資建議。